{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T07:54:39Z","timestamp":1782633279131,"version":"3.54.5"},"reference-count":33,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>In the setting of high hepatitis B virus (HBV) endemicity, we studied the cost\u2010effectiveness of universal HBV screen\u2010and\u2010treat strategies for averting HBV\u2010related morbidity and mortality in Hong Kong, where diagnosis and treatment coverages are low. An age\u2013sex\u2010specific compartmental model for 2000\u20132040 was developed, with the incorporation of population\u2010based screening strategies targeting different age groups. With a one\u2010time HBV screening programme in 2025\u20132029, 3.6%\u20138.9% of HBV\u2010related deaths could be averted. We evaluated the cost\u2010effectiveness of the screening strategies with primary\u2010care\u2010based management in different scenarios with components of annual drug cost levels, screening programme duration, starting year and targeted age groups. Incremental cost\u2010effectiveness ratio (ICER) was calculated, with the willingness\u2010to\u2010pay (WTP) threshold set at USD100,000\/quality\u2010adjusted life years (QALY). At the standard drug cost level, only the screening strategy targeting the 40\u201349\u2009years old is cost\u2010saving. When drug cost decreases to a low level, the strategy targeting the 35\u201349\u2009years old (ICER USD97,042\/QALY gained) is likely to be cost\u2010effective and screening 35\u201359\u2009years old is marginally cost\u2010effective. In probabilistic sensitivity analysis, screening 40\u201349\u2009years old (50%) and 35\u201359\u2009years old (42%) have a half\u2013half probability of being the most cost\u2010effective at USD100,000\/QALY WTP threshold, but increased to 93% for screening 35\u201359\u2009years old at USD150,000\/QALY threshold. From scenario analysis, deferred initiation of screening and unlimited programme duration would increase the ICER. Universal HBV screening targeting individuals aged 35\u201359\u2009years or 40\u201349\u2009years in the general population, with an earlier start and limited duration of the programme, is likely to be cost\u2010effective.<\/jats:p>","DOI":"10.1111\/jvh.70027","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T17:02:50Z","timestamp":1743613370000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cost\u2010Effectiveness of Universal Screen\u2010and\u2010Treat Strategies for Reducing Morbidity and Mortality of Chronic Hepatitis B in a High\u2010Endemicity City"],"prefix":"10.1111","volume":"32","author":[{"given":"Ngai Sze","family":"Wong","sequence":"first","affiliation":[{"name":"JC School of Public Health and Primary Care The Chinese University of Hong Kong  Hong Kong China"},{"name":"Stanley Ho Centre for Emerging Infectious Diseases The Chinese University of Hong Kong  Hong Kong China"},{"name":"S.H. Ho Research Centre for Infectious Diseases The Chinese University of Hong Kong  Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Pui\u2010Chung","family":"Chan","sequence":"additional","affiliation":[{"name":"Stanley Ho Centre for Emerging Infectious Diseases The Chinese University of Hong Kong  Hong Kong China"},{"name":"S.H. Ho Research Centre for Infectious Diseases The Chinese University of Hong Kong  Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2863-9389","authenticated-orcid":false,"given":"Grace Lai\u2010Hung","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics The Chinese University of Hong Kong  Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui Shan","family":"Lee","sequence":"additional","affiliation":[{"name":"Stanley Ho Centre for Emerging Infectious Diseases The Chinese University of Hong Kong  Hong Kong China"},{"name":"S.H. Ho Research Centre for Infectious Diseases The Chinese University of Hong Kong  Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4]]},"reference":[{"key":"e_1_2_9_2_1","volume-title":"Global Hepatitis Report 2024: Action for Access in Low\u2010 and Middle\u2010Income Countries","author":"World Health Organization","year":"2024"},{"key":"e_1_2_9_3_1","volume-title":"Guidelines for the Prevention, Diagnosis, Care and Treatment for People With Chronic Hepatitis B Infection","author":"World Health Organization","year":"2024"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00517-9"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51825"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir199"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)30101-2"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1017\/S095026882300002X"},{"key":"e_1_2_9_9_1","volume-title":"Surveillance of Viral Hepatitis in Hong Kong 2021 Report","author":"Viral Hepatitis Control Office","year":"2022"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz038"},{"key":"e_1_2_9_11_1","unstructured":"Department of Health The Government of the Hong Kong Special Administrative Region \u201cThematic Report on Viral Hepatitis Population Health Survey 2020\u201322 \u201daccessed May 14 2024 https:\/\/www.hepatitis.gov.hk\/english\/health_professionals\/files\/Full_Report_Thematic_report_PHS_2020\u201022.pdf."},{"key":"e_1_2_9_12_1","unstructured":"Department of Health the Government of the Hong Kong Special Administrative Region \u201cManagement of Adult Patients With Chronic Hepatitis B in Primary Care \u201d2023 accessed February 18 2025 https:\/\/www.hepatitis.gov.hk\/english\/health_professionals\/guidelines_recommendations.html."},{"key":"e_1_2_9_13_1","unstructured":"Census and Statistics Department Hong Kong SAR Government \u201cCensus and Statistics Department \u201d2024 accessed July 31 2024 https:\/\/www.censtatd.gov.hk\/en\/."},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468\u20101253(23)00197\u20108"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-10408-5"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.10.027"},{"issue":"6","key":"e_1_2_9_17_1","first-page":"1534","article-title":"Strategy Vaccination Against Hepatitis B in China","volume":"11","author":"Liao X.","year":"2015","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"e_1_2_9_18_1","unstructured":"World Health Organization \u201cGHO\u2014by Category\u2014Hepatitis B (HepB3) Immunization Coverage Estimates by Country \u201daccessed April 13 2023 https:\/\/apps.who.int\/gho\/data\/view.main.80300."},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1086\/599332"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15664"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14330"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.25846"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30204-3"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114681"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13638"},{"key":"e_1_2_9_26_1","unstructured":"Census and Statistics Department Hong Kong Special Administrative Region \u201cHong Kong Monthly Digest of Statistics \u201d2022 accessed November 16 2022 https:\/\/www.censtatd.gov.hk\/en\/data\/stat_report\/product\/B1010002\/att\/B10100022022MM11B0100.pdf."},{"key":"e_1_2_9_27_1","unstructured":"The World Bank \u201cGDP Per Capita (Current US$)\u2014Hong Kong SAR China \u201daccessed January 16 2024 https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=HK."},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.14.138206"},{"key":"e_1_2_9_29_1","volume-title":"Global Health Sector Strategies On, Respectively, HIV, Viral Hepatitis and Sexually Transmitted Infections for the Period 2022\u20132030","author":"World Health Organization","year":"2022"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17120"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14945"},{"key":"e_1_2_9_32_1","unstructured":"United States Agency for International Development \u201cDifferentiated Service Delivery: Multi\u2010Month Drug Dispensing & Decentralized Drug Distribution \u201daccessed July 31 2024 https:\/\/www.usaid.gov\/global\u2010health\/health\u2010areas\/hiv\u2010and\u2010aids\/technical\u2010areas\/differentiated\u2010service\u2010delivery#:~:text=Decentralized%20drug%20distribution%20(DDD)%20for services%20closer%20to%20people's%20homes."},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26113"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S146275"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.70027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T09:57:35Z","timestamp":1745834255000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.70027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1111\/jvh.70027"],"URL":"https:\/\/doi.org\/10.1111\/jvh.70027","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-12-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70027"}}